EpiPen Pricing

Mylan NV (NASDAQ: MYL)'s CEO Heather Bresch could face the wrath of the U.S. Congress on Wednesday given the company's practice of boosting the price of its potential life-saving EpiPen. According to a Bloomberg report, Robert Coury, Bresch's boss, won't be taking the stand on Wednesday. Coury,...